CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Hypertonic Saline with furosemide +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05480722
NCT05480722N/ACompleted

Central Sodium Sensing: Implications for Blood Pressure Regulation

University of Delaware·interventional·Posted Jul 29, 2022·Updated Dec 8, 2025

In Brief

A clinical study evaluating Hypertonic Saline with furosemide and Hypertonic Saline without furosemide for Salt Sensitivity of Blood Pressure. Completed, enrolled 29 participants across 1 site.

Detailed Summary

The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the human brain in older adults and determine if the Na-K-2Cl co-transporter mediates the neurohumoral response to acute hypernatremia. Completion of this project will increase our understanding of blood pressure regulation, which has major public health implications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 29, 2022
Enrollment StartJun 1, 2022
Primary CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 3.9 years ago

Interventions

Hypertonic Saline with furosemideother

Subjects will undergo MRI with a hypertonic saline infusion with NKCC2 antagonism (furosemide). The hypertonic saline will be a 3% NaCl solution infused intravenously at a rate of 0.15 ml/kg/min for 30 minutes; the furosemide will be infused intravenously as a 40 mg bolus in 4mL of isotonic saline (0.9% NaCl) immediately prior to the hypertonic saline infusion.

Hypertonic Saline without furosemideother

Subjects will undergo MRI with a hypertonic saline infusion. The hypertonic saline will be a 3% NaCl solution infused intravenously at a rate of 0.15 ml/kg/min for 30 minutes.